Publications dans lesquelles il/elle collabore avec Felipe De Arriba De La Fuente (26)

2021

  1. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma

    Journal of Thrombosis and Thrombolysis, Vol. 52, Núm. 3, pp. 848-853

  2. Minimal residual disease in multiple myeloma: Something old, something new

    Cancers, Vol. 13, Núm. 17

2019

  1. Increasing therapy-related myeloid neoplasms in multiple myeloma

    European Journal of Clinical Investigation, Vol. 49, Núm. 2

2018

  1. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation

    Hematology, Vol. 23, Núm. 9, pp. 712-718

2017

  1. Cambra system in patients awaiting hematopoietic progenitor cell transplant and high caries risk

    Journal of Clinical and Experimental Dentistry, Vol. 9, Núm. 5, pp. e654-e660

2016

  1. Identification of a new potential mechanism responsible for severe bleeding in myeloma: Immunoglobulins bind the heparin binding domain of antithrombin activating this endogenous anticoagulant

    Haematologica

  2. Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: Kinetics, clinical impact and absence of STAT3 mutations

    British Journal of Haematology, Vol. 172, Núm. 6, pp. 937-946

2015

  1. Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia

    Blood Cancer Journal, Vol. 5

2012

  1. Influence of oral health on mucositis in patients undergoing hematopoietic progenitor cell transplantation (HPCT)

    Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 17, Núm. 1

2009

  1. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.

    Annals of medicine, Vol. 41, Núm. 7, pp. 547-558

2008

  1. Inhibition of proteasome by bortezomib causes intracellular aggregation of hepatic serpins and increases the latent circulating form of antithrombin

    Laboratory Investigation, Vol. 88, Núm. 3, pp. 306-317

  2. Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies

    Haematologica

2004

  1. Genetic variants of the extra-large stimulatory Gs protein alpha-subunit and risk of thrombotic and haemorrhagic disorders

    British Journal of Haematology, Vol. 125, Núm. 5, pp. 621-628

  2. Trasplante de progenitores hematopoyéticos de sangre periférica en España: Análisis de coste

    Medicina Clinica, Vol. 123, Núm. 11, pp. 401-405

2003

  1. Massive intestinal infiltration in a patient with bone T-cell rich diffuse large B cell lymphoma.

    Haematologica, Vol. 88, Núm. 5

2000

  1. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF

    Bone Marrow Transplantation, Vol. 25, Núm. 3, pp. 231-235

1999

  1. Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer

    Bone Marrow Transplantation, Vol. 23, Núm. 6, pp. 621-624

  2. Preleukapheresis peripheral blood CD34+ cells predict progenitor cell collection yield and the necessary number of procedures to undergo [2]

    Haematologica

1998

  1. A radioreceptor assay for mass measurement of inositol (1,4,5)- trisphosphate using saponin-permeabilized outdated human platelets

    Analytical Biochemistry, Vol. 256, Núm. 1, pp. 117-121

  2. Aplastic anaemia induced by ticlopidine after placement of coronary artery stents: Therapeutic role of granulocyte colony-stimulating factor

    Clinical Drug Investigation, Vol. 15, Núm. 3, pp. 261-262